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Aim. To report on the use of indocyanine green (ICG) during surgical removal of pediatric orbital lacrimal duct cysts. Method.
We conducted a retrospective review of our cases of surgical excision of orbital lacrimal duct cysts using intraoperative injection
of indocyanine green (ICG), which was used following inadvertent cyst rupture and volume loss. The dye allowed complete cyst
visualization and complete excision despite volume loss or cyst rupture. Results. The study included 6 children (3 boys, mean age
of 4.2± 0.84 years, range 3–5 years). Mean follow-up period was 9.3 months. All cysts were located in the inferonasal quadrant
of the orbit (4 in the right side). In all cases, ICG was injected into the cyst at the time of surgery following unintentional cyst
rupture. After the dye injection, it was easy to identify the borders of the cyst, permitting complete cyst removal, without any
intra- or postoperative complications. Pathological examination revealed that all cysts were of lacrimal duct origin. Conclusion.
Intraoperative injection of ICG into orbital cysts in children can aid surgeons in identifying cyst borders following inadvertent
rupture, allowing complete removal.
1. Introduction
Dermoid cysts, mucocele, and congenital ocular anomalies
are the most common orbital cystic lesions in children
[1]. However, cysts arising from the lacrimal duct are less
frequently encountered [2–5]. These cystic lesions may be
congenital, inflammatory, or traumatic in origin. Lacrimal
duct cysts can retain communicationwith the lacrimal system
or be completely separated from it. The most common pre-
sentation is that of a cystic mass located in the inferiormedial
orbit, occasionally associated with signs and symptoms of
secondary nasolacrimal duct obstruction [6].Most lesions are
small in size and asymptomatic soon after birth; howeverwith
time theymay enlarge considerably, potentially causing globe
compression which requires early resection.
In order to prevent local recurrence, it is necessary to
remove the entire cyst at the time of surgery without leaving
any residual cyst tissue.Onoccasions, thismay be challenging
since cyst boundaries are not easily apparent, especially
posteriorly. Inadvertent puncture of the cyst capsule may
further limit complete excision.
Indocyanine green (ICG-Akorn Inc., Lake Forest, IL
66045, USA) is a coloring dye that has numerous uses
in ophthalmology with established intraocular, topical, and
intravenous safety [7]. Reports on the use of ICG during
resection of conjunctival cysts were published; however, to
the best of our knowledge, there is only one case report on
the use of this dye during removal of orbital lesions [8].
The purpose of the study is to report on our experience in
using ICG during removal of pediatric orbital cysts, raising
the awareness of surgeons for the possibility of its use during
such surgery.
2. Methods
We reviewed all cases of pediatric orbital lacrimal cysts that
were operated using intralesional ICG injection at the time
of surgery. Data collection included demographics, clinical
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Figure 1: (a) Coronal CT scan showing a 2 cm homogenous inferomedial cystic mass in the right orbit. (b) Cyst exposure through a skin
incision. (c) Intralesional injection of ICG. (d) Capsule demonstration and further exposure. (e) The completely excised cyst.
history, localization of the lesion, imaging findings, surgical
technique, and complications. Pathological analysis, surgical
outcome, and duration of follow-up were also recorded. The
study was approved by the IRB committee of our medical
center and its compliance was in agreement with rules and
regulations.
All procedures were performed under general anesthe-
sia. Surgical approach was via a skin incision or through
the conjunctiva in the fornix. After the cystic lesion was
identified, if leakage was recognized along with loss of cyst
volume, ICG dye was injected into the lesion with a 25-gauge
needle. Cyst borders were readily apparent even though there
was immediate loss of volume subsequent to the injection.
Following delineation of the cyst capsule with the green dye,
complete excision was performed. The skin or conjunctiva
was closed using 7/0 vicryl sutures and the surgical site was
bandaged with a topical antibiotic ointment. All children
were seen one week after surgery and final assessment of
surgical outcome was made at least 6 months afterwards.
3. Results
Six children (3 boys) were included in this study. All children
had orbital imaging preoperatively; two children had com-
puterized tomography (CT), one had magnetic resonance
imaging (MRI), and 3 children had orbital ultrasound. All
lesions were unilateral (4 in the right orbit; 2 in the left orbit),
always located in the inferomedial orbital quadrant. Four
cysts were diagnosed soon after birth due to the presence of
medial subcutaneous swelling seen at the area of the lacrimal
system, accompanied by cystic sensation upon palpation;
however all surgeries were performed after the age of 3
years (mean age 4.2 years ± 0.84, range 3–5 years) when
there was evidence of progressive enlargement causing globe
compression or cosmetic disfigurement unacceptable to the
parents. None of the children were operated on for relief of
nasolacrimal duct obstruction.
Surgical excision was performed through the skin in two
cases and through the conjunctiva in the remaining four
cases. No complications occurred at the time of local ICG
injection. ICG was injected when intraoperative loss of cyst
volume was noted. None of the cysts were connected to the
nasolacrimal duct, and all showed patency of the lacrimal
system on syringing after cyst removal, with no evidence of
any leakage to the surgical site. Therefore, no silicone tube
intubation was required.
A successful outcomewas achieved in all cases. In all cases
the pathology report confirmed complete excision of a cystic
lesion lined with epithelium of lacrimal duct origin. None
of the children had cyst recurrence during follow-up (mean
follow-up 9 months) or any evidence of nasolacrimal duct
obstruction.
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Figure 2: (a) T2 Coronal MRI scan showing a 1.5 cm inferomedial cystic mass in the left orbit. (b) Cyst exposure through a conjunctival
incision. (c) Capsule demonstration after intralesional ICG injection. (d) The completely excised cyst.
3.1. Case Presentations
3.1.1. Case 1. One of the patients had a right inferome-
dial cystic lesion noted soon after birth. The patient was
followed up regularly and when the lesion was growing
considerably, an orbital CT was performed demonstrating
a 2 cm hyperdense homogeneous mass in the inferomedial
aspect of the right orbit, with mild compression of the right
eye (Figure 1(a)). The patient had no symptoms or signs
of nasolacrimal duct obstruction. At the time of surgery a
horizontal skin incision over the cyst was made and the cyst
was exposed (Figure 1(b)). Upon further exposure, the cyst
started to lose volume, and therefore ICG was injected into
the cyst, which allowed improved visualization of the lesion
boundaries (Figures 1(c) and 1(d)) permitting its complete
excision (Figure 1(e)).Thepatientwas treated twice a daywith
Maxitrol ointment (dexamethasone with polymyxin B and
neomycin) over the surgical wound. Pathology examination
identified complete excision of a cyst lined with epithelium
of lacrimal duct origin. Postoperatively, the patient was
asymptomatic and no cyst recurrence was noted.
3.1.2. Case 2. A second patient was examined in the clinic
for evaluation of a left inferomedial orbital cyst that was
recognized since the age of 3 months. The patient had a
Doppler ultrasound examination which identified a cystic
lesion with a clear liquid content. During follow-up there
was evidence of progressive enlargement of the lesion.Orbital
MRI performed shortly before surgery demonstrated a 0.7 ×
1.5 cm oval mass with clear fluid contents located in the
left inferomedial orbit, causing mild globe compression
(Figure 2(a)). This lesion was surgically resected through a
conjunctival incision. ICG was injected into the cyst at the
time of surgery when loss of volumewas noted by the surgeon
(Figures 2(b)–2(d)).
The patient was treated with topical chloramphenicol
5% ointment over the surgical wound. Pathological analysis
identified a cyst lined with epithelium of lacrimal duct
origin. During the 6-month follow-up period no surgical
complications or cyst recurrence were noted.
4. Discussion
By using intralesional ICG injection, we were able to com-
pletely remove lacrimal duct orbital cysts in children, even
though unintentional volume loss occurred earlier, without
any complications or recurrence. This dye is frequently used
in ophthalmology, including during orbital surgery, with an
established safety profile in humans [7].
Kobayashi et al. used ICG during removal of an acquired
conjunctival cyst [9]. They noted that following intrale-
sional injection the cyst became clearly visible, and staining
remained even after an inadvertent perforation of the cyst
capsule that caused immediate collapse. Chan et al. also
reported on the use of ICG during similar conjunctival
surgery [10]. Others reported on the use of different sub-
stances, including sodium hyaluronate or Healon V and
Trypan blue during excision of conjunctival cysts [11, 12].
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Injecting a mixture of ICG with a viscoelastic material is
another useful technique [8]. However, according to our
experience there is no need to use a viscoelastic material
as well, since it may not be readily available for all orbital
surgeons and it increases the cost of surgery.
To the best of our knowledge, our study is the first to
report on the use of ICG for demonstration of orbital cysts
during pediatric orbital surgery, although its use has been
reported earlier in an adult [8]. Using this dye, wewere able to
completely remove the cysts even though partial or complete
collapse of the lesion typically occurred.
In conclusion, we believe that ICG has a role in pedi-
atric orbital lacrimal cyst surgery, helping with improved
visualization of the cyst capsule and allowing complete cyst
removal, especially with unintentional rupture of the cyst and
volume loss that occurred earlier.
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